InvestorsHub Logo
Followers 1322
Posts 247641
Boards Moderated 58
Alias Born 12/07/2009

Re: None

Tuesday, 08/22/2023 12:46:29 PM

Tuesday, August 22, 2023 12:46:29 PM

Post# of 2791
$NBIO New HOD .065 +6.47% Nascent CEO, Sean Carrick, commented, "this is an exciting development milestone for Nascent. Phase I data was shown to be safe in five ascending independent cohorts. The data also suggested favorable clinical outcomes in various stages of disease development, that we hope to build upon in Phase II and better understand just how effective this treatment can be for patients suffering with brain cancer". The summarized Phase I data can be seen here in the poster presented at ASCO 2023.
Bullish
Bullish

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News